Hualv Bioscience: It is expected that the net profit in 2025 will be between 100 million and 130 million yuan.

HuaLu Bio announced that it is expecting a net profit of 100 million yuan to 130 million yuan for the year 2025, compared to a loss of 47.56 million yuan in the same period last year. It is also forecasted that the operating income will be between 12 billion yuan and 14 billion yuan, compared to 10.32 billion yuan in the same period last year, representing a year-on-year growth of 16.27% to 35.64%. The improvement in performance is mainly attributed to the simultaneous increase in sales unit price and sales volume.